维普期刊资源整合服务平台（V6.5）

370篇 您的检索式：作者名="Engelman JA"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	Targeted downregulation of caveolin- 1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade 显示文摘	Galbiati F Volonte D Engelman JA	1998	EMBO J1998，17，22：	2
2	The PI3 K path way as drug target in human cancer 显示文摘	Courtney KD Corcoran RB Engelman JA	2010	J Clin Oncol2010，28，6：	1
3	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T etal	2007	Science2007，316，5827：	1
4	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T		0，，5827：	1
5	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
6	Mechanisms of acquired resistance to epidermal growth receptor tyrosine kinase inhibitors in non-small cell lung cancer显示文摘	Engelman JA J(o)nne PA		0，，10：	1
7	MET amplification leads to gefitinib resistance in lung cancer by activating ErbB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
8	Ferrule design and fracture resistance of endodontically treated teeth显示文摘	Sorensen JA Engelman MJ	1990	J Prosthet Dent1990，63，：	1
9	Caveolin-2 deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae显示文摘	Razani B Wang XB Engelman JA Battista M Lagaud G Zhang XL	2002	Mol Cell Biol2002，22，：	1
10	Ferrule design and fracture re-sistance of endodontically treated teeth显示文摘	Soresen JA Engelman MJ	1990	J Prosthet Dent1990，63，：	1
11	Targeting the PI3K signaling pathway in cancer显示文摘	Wong KK Engelman JA Cantley LC	2010	Curr Opin Genet Dev2010，20，1：	1
12	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
13	Targeting the PI3K signaling pathway in cancer显示文摘	Wong KK Engelman JA Cantley LC	2010	Current Opinion2010，2，20：	1
14	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
15	Targeting PI3K signaling in cancer: oppor- tunities, challenges and limitations 显示文摘	Engelman JA	2009	Nature Reviews of Cancer2009，9，：	1
16	MET am- plification leads to gefitinib resistance in lung cancer by ac- tivating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
17	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
18	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer显示文摘	Engelman JA Mukohara T Zejnullahu K	2006	J Clin Invest2006，116，10：	1
19	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘	Engelman JA Chen L Tan X	2008	Nat Med2008，14，12：	1
20	Constitutively active mitegen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis 显示文摘	Engelman JA Berg AH Lewis RY	1999	]Biol Chem1999，274，35：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示